Hospital de Granollers   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Barcelona Spain (1329)

Organization Overview

First Clinical Trial
2005
NCT00338390
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Fundació Hospital-Asil de Granollers (Barcelona, Spain) | Fundació Hospital de Granollers | Fundació Privada Hospital Asil de Granollers | Fundació Privada Hospital Asil de Granollers (HAG) | Hospital de Granollers | Hospital general de Granollers | Julia Tárrega, PhD

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 4)

Anemia, Iron-Deficiency (Phase 4)

Colorectal Neoplasms (Phase 4)

Communicable Diseases (Phase 4)

Deficiency Diseases (Phase 4)

HIV Infections (Phase 3)

Infections (Phase 4)

Neoplasms (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Rectal Neoplasms (Phase 4)

Stroke (Phase 4)

Surgical Wound (Phase 4)

Surgical Wound Infection (Phase 4)

Wound Infection (Phase 4)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 16